Aeterna Zentaris (AEZS) News Today → A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad) Free AEZS Stock Alerts $8.52 -0.07 (-0.81%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 8:05 AM | finance.yahoo.comAeterna Zentaris Announces Details Regarding Transaction with CeaproMay 17 at 8:00 AM | globenewswire.comAeterna Zentaris Announces Details Regarding Transaction with CeaproMay 16 at 3:26 AM | americanbankingnews.comAeterna Zentaris (NASDAQ:AEZS) Receives New Coverage from Analysts at StockNews.comMay 15 at 4:57 AM | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Reports First Quarter 2024 Financial ResultsMay 14, 2024 | washingtonpost.comAeterna Zentaris: Q1 Earnings SnapshotMay 14, 2024 | globenewswire.comAeterna Zentaris Reports First Quarter 2024 Financial ResultsMay 11, 2024 | americanbankingnews.comAeterna Zentaris Inc. (NASDAQ:AEZS) Short Interest UpdateMay 8, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Aeterna Zentaris (NASDAQ:AEZS)May 3, 2024 | marketbeat.comTrading was temporarily halted for "AEZS" at 07:05 PM with a stated reason of "News pending."May 1, 2024 | globenewswire.comAeterna Zentaris Announces Effective Date of Share ConsolidationApril 28, 2024 | finance.yahoo.com12 ChatGPT Penny Stock Picks Right NowApril 2, 2024 | theglobeandmail.comAuxly Cannabis Group: Top 10 Undervalued Healthcare Sector Stocks on TSX (XLY)March 28, 2024 | globenewswire.comCeapro Receives Final Court Approval for Merger with Aeterna ZentarisMarch 27, 2024 | benzinga.comAEterna Zentaris: Q4 Earnings InsightsMarch 27, 2024 | globenewswire.comAeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyMarch 13, 2024 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsMarch 12, 2024 | globenewswire.comAeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsFebruary 28, 2024 | thestreet.comAeterna Zentaris Inc.February 26, 2024 | globenewswire.comLeading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical CompanyFebruary 15, 2024 | globenewswire.comAeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with CeaproDecember 14, 2023 | marketbeat.comTrading was temporarily halted for "AEZS" at 07:12 AM with a stated reason of "News pending."November 14, 2023 | morningstar.comAEterna Zentaris Inc AEZSNovember 9, 2023 | msn.comAeterna Zentaris GAAP EPS of -$0.85November 9, 2023 | finance.yahoo.comAeterna Zentaris Reports Third Quarter 2023 Financial ResultsNovember 6, 2023 | theglobeandmail.comAEterna Zentaris: Stocks trading at Less Than Cash Value on TSX (AEZS)October 30, 2023 | theglobeandmail.comAEterna Zentaris: Top 10 Undervalued Biotechnology Industry Stocks (AEZS)October 11, 2023 | finance.yahoo.comAeterna Zentaris to Participate at the Virtual Investor Ask the CEO ConferenceSeptember 12, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc down on Monday (AEZS)September 5, 2023 | finance.yahoo.comAeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 15, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc flat on Tuesday (AEZS)August 10, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Aeterna Zentaris (AEZS)August 9, 2023 | finance.yahoo.comAeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue EstimatesJuly 13, 2023 | finance.yahoo.comAeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate UpdateJune 15, 2023 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Announces Results of Virtual 2023 Meeting of ShareholdersMay 26, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc down on Friday (AEZS)May 17, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc down on Tuesday (AEZS)May 15, 2023 | finance.yahoo.comAeterna Zentaris Announces Virtual 2023 Meeting of ShareholdersMay 12, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)May 10, 2023 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Reports First Quarter 2023 Financial ResultsMay 9, 2023 | finance.yahoo.comAeterna Zentaris Reports First Quarter 2023 Financial ResultsApril 27, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc down on Wednesday (AEZS)April 6, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc up on Thursday (AEZS)April 6, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc up on Wednesday (AEZS)April 6, 2023 | finance.yahoo.comAeterna (AEZS) Falls 5% on US Sales Halt of Growth Hormone DrugApril 5, 2023 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Provides Update on Macrilen (Macimorelin), Reiterates Advancement of Pediatric DETECT TrialApril 5, 2023 | finance.yahoo.comAeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT TrialMarch 23, 2023 | finance.yahoo.comAeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue EstimatesMarch 23, 2023 | financialpost.comAeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 16, 2023 | finance.yahoo.comPharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)January 17, 2023 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. AEZS Media Mentions By Week AEZS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEZS News Sentiment▼0.450.50▲Average Medical News Sentiment AEZS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEZS Articles This Week▼70▲AEZS Articles Average Week Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADXN News NCNA News ATHE News MTEM News GHSI News CMMB News GRTX News MBRX News UPC News MIRA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEZS) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA once-in-a-century investment opportunityStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
